Instituto de Oftalmología y Ciencias Visuales, Escuela de Medicina, Tecnológico de Monterrey, Monterrey, Mexico.
Department of Ophthalmology, University Hospital Leipzig, Liebigstr. 10-14, 04103, Leipzig, Germany.
Sci Rep. 2021 Feb 26;11(1):4738. doi: 10.1038/s41598-020-79288-w.
To analyze functional and anatomical response patterns to dexamethasone (DEX) implant in diabetic macular edema (DME), to describe proportion of responders and non-responders, and to propose a new DME grading system. Retrospective, multicenter, observational cohort study. Naïve and non-naïve DME patients were treated with DEX, with visual acuity (VA) ≥ 0.2 logMAR and central subfield thickness (CST) of ≥ 300 µm. Functional and anatomical responses were graded after 2 and 4 months, and categorized as early and stable improvement, early and progressive improvement, pendular response, delayed improvement, and persistent non-response. 417 eyes were included (175 treatment naïve eyes). Compared to non-naïve eyes, naïve eyes showed a very good functional response (VA gain ≥ 10 letters) more frequently after 2 and 4 months (56% and 57% [naïve] vs. 33% and 28% [non-naïve], p < 0.001). A VA gain < 5 letters (non-response) after 2 and 4 months was seen in 18% and 16% of naïve eyes, and in 49% and 53% of non-naïve eyes (p < 0.001). A lack of anatomical response was rare in both groups, but more frequently in non-naïve eyes (12% vs. 4%, p = 0.003). Functionally and anatomically, naïve eyes showed most frequently an early and stable improvement (functionally: 77/175 44%; anatomically: 123/175 eyes, 70%). Most non-naïve eyes experienced no significant improvement functionally (97/242 eyes, 40%), despite a mostly early and stable improvement anatomical response pattern (102/242 eyes, 42%). Functional but not anatomical response patterns were influenced by baseline VA. Naïve and non-naïve eyes show different functional and anatomical response patterns to DEX implant. Functional non-responders are rare in naïve eyes, whereas anatomical non-response is unusual in both groups.
为了分析地塞米松(DEX)植入物对糖尿病性黄斑水肿(DME)的功能和解剖学反应模式,描述反应者和非反应者的比例,并提出一种新的 DME 分级系统。回顾性、多中心、观察性队列研究。对 DEX 治疗的初治和非初治 DME 患者进行治疗,最佳矫正视力(VA)≥0.2 logMAR 和中心视网膜厚度(CST)≥300μm。在 2 个月和 4 个月后对功能和解剖学反应进行分级,并分为早期和稳定改善、早期和进展性改善、摆动反应、延迟改善和持续无反应。共纳入 417 只眼(175 只初治眼)。与非初治眼相比,初治眼在 2 个月和 4 个月时更常出现良好的功能反应(VA 提高≥10 个字母)(56%和 57%[初治]比 33%和 28%[非初治],p<0.001)。初治眼在 2 个月和 4 个月时 VA 提高<5 个字母(无反应)分别为 18%和 16%,而非初治眼分别为 49%和 53%(p<0.001)。两组中解剖学无反应均罕见,但非初治眼更常见(12%比 4%,p=0.003)。初治眼在功能和解剖学上最常出现早期和稳定的改善(功能:77/175 眼,44%;解剖学:123/175 眼,70%)。大多数非初治眼在功能上没有明显改善(97/242 眼,40%),尽管解剖学上的早期和稳定的改善反应模式居多(102/242 眼,42%)。功能但不是解剖学反应模式受基线 VA 的影响。初治和非初治眼对地塞米松植入物有不同的功能和解剖学反应模式。初治眼的功能无反应者罕见,而两组的解剖无反应者均不常见。